[9,9-dioxopromethazine (Prothanon) at the trial in hay fever].
D000328:Adult; D002986:Clinical Trials as Topic; D005221:Fatigue / Q000139:chemically induced; D005260:Female; D006634:Histamine H1 Antagonists / Q000627:therapeutic use*; D006801:Humans; D006993:Hypnotics and Sedatives / Q000627:therapeutic use; D008297:Male; D009883:Ophthalmic Solutions; D010919:Placebos; D011398:Promethazine / Q000009:adverse effects / Q000627:therapeutic use*; D006255:Rhinitis, Allergic, Seasonal / Q000188:drug therapy*
D006634:Histamine H1 Antagonists; D006993:Hypnotics and Sedatives; D009883:Ophthalmic Solutions; D010919:Placebos; D011398:Promethazine
9.9-Dioxopromethazin (Prothanon) in der Erprobung bei Heuschnupfen.